-
Walgreens Boots Alliance reportedly exploring $4B plus sale of Shields Health Solutions
The specialty pharmacy business could be valued at more than $4 billion in a sale, per a Bloomberg report, which cited people familiar with the matter. -
Walgreens' specialty pharmacy to distribute Verrica's Ycanth
Ycanth is the first FDA-approved therapy for the treatment of molluscum contagiosum.